2'',3'',5''-Triacetyl-azacytidine (CAS 10302-78-0): A Leading Prodrug for DNA Methyltransferase Inhibition
Discover the power of 2'',3'',5''-Triacetyl-azacytidine, a critical pharmaceutical intermediate and prodrug form of 5-azacytidine. Expertly manufactured and supplied for advanced research in epigenetic modifications and therapeutic development.
Get a Quote & SampleUnlocking Therapeutic Potential with a Superior DNA Methyltransferase Inhibitor
Triacetyl-azacytidine
As a prominent manufacturer and supplier in China, we offer high-purity Triacetyl-azacytidine (CAS 10302-78-0), a vital prodrug for 5-azacytidine. Its efficacy as a DNA methyltransferase inhibitor is crucial for reversing epigenetic changes associated with diseases like cancer and myelodysplastic syndromes. Partner with us for reliable sourcing and competitive pricing.
- Leading DNA Methyltransferase Inhibitor: Essential for research into reversing harmful epigenetic changes.
- Oral Prodrug Advantage: Facilitates enhanced absorption compared to its parent compound.
- High Purity Pharmaceutical Intermediate: Ideal for advanced drug discovery and formulation.
- Reliable Supplier in China: Secure your supply chain with a trusted manufacturer.
Key Advantages of Sourcing Triacetyl-azacytidine
Superior Epigenetic Modulation
Our Triacetyl-azacytidine acts as a potent inhibitor of DNA methyltransferase, enabling researchers to effectively explore and reverse aberrant epigenetic modifications linked to various diseases.
Enhanced Oral Bioavailability
As a prodrug, this compound offers improved oral absorption characteristics, making it a more convenient and potentially effective option for therapeutic development.
Quality and Consistency Assured
We guarantee the highest purity and batch-to-batch consistency, ensuring reliable performance for your critical research and manufacturing needs. Buy with confidence from a leading supplier.
Applications in Pharmaceutical Research and Development
Cancer Therapeutics Research
Investigate the role of DNA methylation in oncogenesis and explore therapeutic strategies for various cancers using this potent epigenetic modifier.
Myelodysplastic Syndromes (MDS) Treatment
Utilize Triacetyl-azacytidine in research focused on reversing hypermethylation associated with MDS and improving patient outcomes.
Epigenetic Drug Discovery
A crucial intermediate for scientists developing novel drugs that target epigenetic mechanisms for a range of therapeutic indications.
Pharmaceutical Formulation Development
Incorporate this high-quality intermediate into your formulation processes for advanced drug products.